Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Hong MH, Lee S, Kim CG, Son W, Park JW, Yoon SO, Shin SJ, Hong HJ, Koh YW, Lim JY, Park YM, Wee CW, Kim KH, Lee CG, Kim JW, Kim J, Suh PS, Kuh SU, Kim DH, Sim NS, Kim HR

Open source

DOI: 10.1016/j.oraloncology.2026.108114
Published: 2026 Sep 4
Container: Oral oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.oraloncology.2026.108114,
  title = {Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].},
  author = {Hong MH and Lee S and Kim CG and Son W and Park JW and Yoon SO and Shin SJ and Hong HJ and Koh YW and Lim JY and Park YM and Wee CW and Kim KH and Lee CG and Kim JW and Kim J and Suh PS and Kuh SU and Kim DH and Sim NS and Kim HR},
  year = {2026},
  journal = {Oral oncology},
  doi = {10.1016/j.oraloncology.2026.108114},
  url = {https://doi.org/10.1016/j.oraloncology.2026.108114}
}

RIS

TY  - JOUR
TI  - Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].
AU  - Hong MH
AU  - Lee S
AU  - Kim CG
AU  - Son W
AU  - Park JW
AU  - Yoon SO
AU  - Shin SJ
AU  - Hong HJ
AU  - Koh YW
AU  - Lim JY
AU  - Park YM
AU  - Wee CW
AU  - Kim KH
AU  - Lee CG
AU  - Kim JW
AU  - Kim J
AU  - Suh PS
AU  - Kuh SU
AU  - Kim DH
AU  - Sim NS
AU  - Kim HR
PY  - 2026
JO  - Oral oncology
DO  - 10.1016/j.oraloncology.2026.108114
UR  - https://doi.org/10.1016/j.oraloncology.2026.108114
ER  -

APA

MH, H., S, L., CG, K., W, S., JW, P., SO, Y., SJ, S., HJ, H., YW, K., JY, L., YM, P., CW, W., KH, K., CG, L., JW, K., J, K., PS, S., SU, K., DH, K., NS, S., & HR, K. (2026). Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].. Oral oncology. https://doi.org/10.1016/j.oraloncology.2026.108114

Source records

pubmed · retrieved 2026-09-26T10:47:45.496Z
europe-pmc · retrieved 2026-09-26T10:47:45.513Z